References
- Head G. A., de Jong W. Central versus peripheral adrenergic regulation of blood pressure: contributions to the actions of alpha-methyldopa. Adrenergic Blood Pressure Regulation, W. Birkenhager, F. B. Struyker-Boudier, H. Struyker-Boudier. Excerpta Medica, Amsterdam 1985; 103–113
- Finch L., Haeusler G. Further evidence for a central hypotensive action of α-methyldopa in both rat and cat. Br J Pharmacol. 1973; 47: 217–228
- Kobinger W. Central alpha-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol. 1978; 81: 40–100
- Bousquet P., Feldman J., Schwartz J. Central cardiovascular effects of alpha adrenergic drugs: Differences between catecholamines and imidazolines. J Pharmacol Exp Ther. 1984; 230: 232–236
- Head G. A., Korner P. I., Lewis S. L., Badoer E. Contribution of noradrenergic and serotonergic neurons to the circulatory effects of centrally acting clonidine and alpha-methyldopa in rabbits. J Cardiovasc Pharmacol. 1983; 5: 945–953
- Bricca G., Dontenwill M., Molines A., Feldman J., Tibirica E., Belcourt A., Bousquet P. Rilmenidine selectivity for imidazoline receptors in human brain. Eur J Pharmacol. 1989; 163: 373–377
- Sannajust F., Head G. A. Rilmenidine induced hypotension involves imidazoline preferring receptors in conscious rabbits. J Cardiovasc Pharmacol. 1994; 23: 42–50
- Head G. A., Sannajust F. Importance of imidazoline receptors in the cardiovascular responses to clonidine and rilmenidine in conscious rabbits. Fundam Clin Pharmacol. 1992; 6(Suppl 1)31s–43s
- Head G. A., Godwin S. J., Sannajust F. Differential receptors involved in the cardiovascular effects of clonidine and rilmenidine in conscious rabbits. J Hypertens. 1993; 11: S322–S323
- Ernsberger P. R., Westbrooks K. L., Christen M. O., Schafer S. G. A second generation of centrally acting antihypertensive agents act on putative I(1)-imidazoline receptors. J Cardiovasc Pharmacol 1992; 20: s1–s10
- Badoer E., Head G. A., Korner P. I. Effects of intracisternal and intravenous alpha-methyldopa and clonidine on haemodynamics and baroreceptor-heart rate reflex properties in conscious rabbits. J Cardiovasc Pharmacol. 1983; 5: 760–767
- Sannajust F., Head G. A. Effect of rilmenidine on the baroreflex control of renal nerve activity. J Hypertens. 1993; 11: S328–S329
- Elghozi J. L., Head G. A., Wolf W. A., Anderson C. R., Korner P. I. Importance of spinal noradrenergic pathways in cardiovascular reflexes and central actions of clonidine and alpha-methyldopa in the rabbit. Brain Res. 1989; 499: 39–52
- U'Prichard D. C., Bechtel W. D., Rouot B. M., Snyder S. H. Multiple apparent alpha-noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamine. Mol Pharmacol. 1979; 16: 47–60
- Head G. A., Burke S. B. Importance of central noradrenergic and serotonergic pathways in the cardiovascular actions of rilmenidine and clonidine. J Cardiovasc Pharmacol. 1991; 18: 819–826
- Schlicker E., Armah B. I., Gothert M. Central presynaptic alpha 2-autoreceptors are involved in the blood pressure-lowering effect of moxonidine. J Cardiovasc Pharmacol. 1990; 16: 15–22
- Jonsson G. Chemical neurotoxins as denervation tools in neurobiology. Ann Rev Neurosci. 1980; 3: 169–187
- Head G. A., Korner P. I. Mechanisms of acute hypertension and bradycardia following intracisternal 6-hydroxydopamine in conscious rabbits. Eur J Pharmacol. 1980; 66: 111–115
- Head G. A., Korner P. I. Cardiovascular functions of brain serotonergic neurons in the rabbit as analysed from the acute and chronic effects of 5,6-dihydroxytryptamine. J Cardiovasc Pharmacol. 1982; 4: 398–408
- Head G. A. Central monoamine neurons and cardiovascular control. Kidney Int. 1992; 41(Suppl. 37)S8–S13
- Scheinin M., Schwinn D. A. The locus coeruleus - site of hypnotic actions of alpha2- adrenoceptor agonists. Anesthesiology. 1992; 76: 873–875